Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5849087 | 1.00 | TLR4 (0.34) | TLR4CYP1A2 | |
| SCHEMBL7770616 | 1.00 | TLR4 (0.34) | TLR4CYP1A2 | |
| SCHEMBL7770614 | 1.00 | TLR4 (0.34) | TLR4CYP1A2 | |
| SCHEMBL7770973 | 1.00 | TLR4 (0.34) | TLR4CYP1A2 | |
| SCHEMBL7770976 | 1.00 | TLR4 (0.34) | TLR4CYP1A2 | |
| SCHEMBL7912118 | 0.94 | CYP1A2 (0.35) | TLR4CYP1A2 | |
| SCHEMBL7912112 | 0.94 | CYP1A2 (0.35) | TLR4CYP1A2 | |
| SCHEMBL7912127 | 0.94 | CYP1A2 (0.35) | TLR4CYP1A2 | |
| SCHEMBL7912123 | 0.94 | CYP1A2 (0.35) | TLR4CYP1A2 | |
| SCHEMBL9978904 | 0.91 | TLR4 (0.35) | TLR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026086676-A1 | LIQUID CRYSTAL COMPOSITION, SWITCHABLE DISPLAY, AND OPERATION METHOD | 镭亚股份有限公司 | 2026-04-30 | — | — | WO | disclosed |
| EP-4219656-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | Merck Patent GmbH (DE) | 2023-08-02 | — | — | EP | disclosed |
| EP-4194529-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | Merck Patent GmbH (DE) | 2023-06-14 | — | — | EP | disclosed |
| CN-112409118-A | Method for electrochemically synthesizing trans-4- (trans-4' -alkylcyclohexyl) cyclohexyl vinyl liquid crystal monomer | 惠泽化学科技(濮阳)有限公司 | 2021-02-26 | — | — | CN | disclosed |
| EP-2977428-B1 | POLYMERIZABLE COMPOUND-CONTAINING LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DAINIPPON INK & CHEMICALS (JP) | 2018-05-02 | — | — | EP | disclosed |
| EP-2955570-B1 | LIQUID CRYSTAL DISPLAY ELEMENT AND MANUFACTURING METHOD FOR SAME | DAINIPPON INK & CHEMICALS (JP) | 2018-03-28 | — | — | EP | disclosed |
| EP-3228682-A2 | NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | DIC Corporation (JP) | 2017-10-11 | — | — | EP | disclosed |
| US-9695361-B2 | Liquid crystal composition and liquid crystal display element using the same | DIC CORPORATION (JP) | 2017-07-04 | — | — | US | disclosed |
| US-7026021-B2 | Fluorinated heterocycles and their use in liquid-crystal mixtures | MERCK PATENT GMBH (DE) | 2006-04-11 | — | — | US | disclosed |
| US-6955838-B2 | Fluorinated polycycles and their use in liquid-crystal mixtures | CLARIANT INTERNATIONAL LTD. (CH) | 2005-10-18 | — | — | US | disclosed |
| US-20050098762-A1 | 4,6,7-Trifluoro-benzo[b]naphtho[2,3-d]furan derivatives | MERCK PATENT GMBH (DE) | 2005-05-12 | — | — | US | disclosed |
| US-6887533-B2 | Fluorinated oxaanthracenes and their use in liquid-crystal mixtures | CLARIANT INTERNATIONAL, LTD. (CH) | 2005-05-03 | — | — | US | disclosed |
| US-20050056812-A1 | Fluorinated heterocycles and their use in liquid-crystal mixtures | MERCK PATENT GMBH (DE) | 2005-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050056812-A1 | Fluorinated heterocycles and their use in liquid-crystal mixtures | CHRM1, SCO2, CHRM2 | TLR4 4041/4885CYP1A2 196/4885 |
| US-20050098762-A1 | 4,6,7-Trifluoro-benzo[b]naphtho[2,3-d]furan derivatives | CCNT1, CBR1, SCO2 | TLR4 1944/4885CYP1A2 213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.